Healthcare Services

Cannabis pharmaceuticals market insights on opportunities

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Cannabis Pharmaceuticals Market Compare Between 2026 And 2030?

The size of the cannabis pharmaceuticals market has seen exponential expansion recently. Projections indicate it will expand from $9.43 billion in 2025 to $14.74 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 56.3%. Historically, this growth stemmed from factors such as heightened acknowledgment of cannabinoids’ therapeutic advantages, an increase in medical cannabis prescriptions, the presence of initial cannabis-derived medications, the rise of hospital-managed pain programs, and regulatory clearances for specific cannabis pharmaceutical products.

The cannabis pharmaceuticals market is projected for significant expansion in the coming years. By 2030, its valuation is anticipated to reach $85.68 billion, advancing with a compound annual growth rate (CAGR) of 55.3%. This projected growth is driven by several factors, including heightened investments in clinical trials for cannabis-based drugs, an increasing need for consistent cannabinoid formulations, the broadening scope of neurological and oncology applications, greater integration of cannabis pharmaceuticals within hospital settings, and enhanced regulatory alignment across various markets. Key trends characterizing this period involve the increasing creation of prescription-strength cannabis medications, a magnified focus on clinical validation and trials, expanding utility in neurological and pain-related conditions, the growth of regulated pharmaceutical development pipelines, and a stronger emphasis on accurate dosage.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cannabis-pharmaceuticals-global-market-report

Which Factors Are Influencing The Growth Of The Cannabis Pharmaceuticals Market?

The increasing occurrence of epilepsy is projected to fuel the cannabis pharmaceuticals market in the coming years. This condition is a neurological ailment marked by repeated, spontaneous seizures stemming from irregular electrical impulses within the brain. The growing number of epilepsy instances can be ascribed to improved diagnostic methods, greater public awareness, and more comprehensive reporting, in addition to possible environmental, genetic, and lifestyle factors. Cannabis-based medicines offer a promising avenue for managing epilepsy, employing cannabinoids such as CBD to lessen the occurrence and intensity of seizures in individuals who are resistant to conventional anti-epileptic medications. For example, data from February 2024 published by the World Health Organization, a global health agency based in Switzerland, indicates that the global population afflicted with epilepsy reached approximately 50 million in 2024. Consequently, the escalating incidence of epilepsy is stimulating expansion within the cannabis pharmaceuticals market.

What Segment Categories Shape The Cannabis Pharmaceuticals Market Segment Landscape?

The cannabis pharmaceuticals market covered in this report is segmented –

1) By Product Type: Cannabinoid-Based Pharmaceuticals, Synthetic Cannabinoids

2) By Therapeutic Application: Cancer, Neurological Disorders, Pain Management

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Government-Authorized Medical Cannabis Dispensaries

Subsegments:

1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination of THC and CBD Pharmaceuticals, Other Cannabinoid-Based Formulations

2) By Synthetic Cannabinoids: Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists

Which Trends Are Influencing Demand In The Cannabis Pharmaceuticals Market?

Leading entities within the cannabis pharmaceuticals market are prioritizing the creation of novel products, specifically advanced medical cannabis formulations, aimed at treating various medical ailments and enhancing patient results. These advanced formulations denote cannabis-derived products meticulously crafted for optimal therapeutic application, featuring exact dosages of cannabinoids such as THC and CBD. As an illustration, in April 2024, Canexis Pharma AG, a pharmaceutical firm situated in Switzerland, obtained manufacturing and narcotics permits from Swissmedic for cannabis pharmaceutical products. Such authorizations enable the company to manufacture high-quality medicinal active compounds sourced from CBD and THC. This progress strategically places Canexis to cater to the increasing demand for medical cannabis both domestically in Switzerland and internationally. Securing these licenses illustrates the company’s adherence to strict regulatory requirements, thereby bolstering its reputation and capacity to participate in the swiftly expanding medical cannabis market.

Who Are The Companies Operating Across The Cannabis Pharmaceuticals Market Value Chain?

Major companies operating in the cannabis pharmaceuticals market are Tilray Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Aphria Inc., Cronos Group, GW Pharmaceuticals plc, Jazz Pharmaceuticals plc, Organigram Holdings Inc., Aleafia Health Inc., Avicanna Inc., Enveric Biosciences Inc., Auxly Cannabis Group Inc., Emerald Health Therapeutics Inc., Medical Marijuana Inc., Valens Company Inc., Curaleaf Holdings Inc., Trulieve Cannabis Corp., Green Thumb Industries Inc., Cresco Labs Inc., Columbia Care Inc., Acreage Holdings Inc.

Get The Full Cannabis Pharmaceuticals Market Report:

https://www.thebusinessresearchcompany.com/report/cannabis-pharmaceuticals-global-market-report

Which Geographic Region Dominates The Cannabis Pharmaceuticals Market?

North America was the largest region in the cannabis pharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabis pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cannabis Pharmaceuticals Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cannabis-pharmaceuticals-global-market-report

Browse Through More Reports Similar to the Global Cannabis Pharmaceuticals Market 2026, By The Business Research Company

Cannabis Cultivation Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-cultivation-global-market-report

Cannabis Capsule Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-capsule-global-market-report

Pharmaceuticals Market 2026

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795